Cyclophosphamide‐induced hemorrhagic cystitis: A review of 100 patients

Cancer

Volumn 61, Issue 3, 1988, Pages 451-457

  Stillwell, Thomas J ^a   Benson, Ralph C ^a  

^a DEPARTMENT OF UROLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE;

BLADDER CARCINOMA; CYSTECTOMY; CYSTITIS; CYTOLOGY; FEMALE; HEMATURIA; HEMORRHAGIC CYSTITIS; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; URINE CYTOLOGY;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; CYSTITIS; CYSTOSCOPY; FEMALE; FOLLOW-UP STUDIES; HEMATURIA; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 0023840207     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19880201)61:3<451::AID-CNCR2820610308>3.0.CO;2-G     Document Type: Article

References (43)

1. Cyclophosphamide cystitis: Identification of acrolein as the causative agent
2. Acrolein, the causative factor of urotoxic side‐effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide
3. Alkylating agents
4. Cyclophosphamide and urinary bladder toxicity
5. Clinical pharmacology and preliminary evaluation of Cytoxan (cyclophosphamide)
6. Hemorrhagic cystitis and cytomegalic inclusions in the bladder associated with cyclophosphamide therapy
7. Cyclophosphamide‐induced hemorrhagic cystitis in children with leukemia
8. Cyclophosphamide cystitis
9. Folgen am harnbereitenden und harnableitenden System während Cyclophosphamid‐Therapie
10. Urinary complications of cyclophosphamide therapy: Etiology, prevention, and management
11. Cyclophosphamide and hemorrhagic cystitis
12. Bladder toxicity with chronic oral cyclophosphamide therapy in nonmalignant disease
13. Urinary‐bladder fibrosis and telangiectasia associated with long‐term cyclophosphamide therapy
14. Pathology of high dose intermittent cyclophosphamide therapy
15. A preliminary clinical study of cyclophosphamide
16. Clinical evaluation of cyclophosphamide: A new agent for the treatment of children with acute leukemia
17. A light and electron microscopic study of the effects of a single dose of cyclophosphamide on various organs in the rat: I. The urinary bladder
18. Urinary‐bladder toxicity following pelvic irradiation and simultaneous cyclophosphamide therapy
19. Chronic hematuria and localized bladder damage following combined cyclophosphamide and local radiotherapy
20. Cytological study of the effect of cyclophosphamide on the epithelium of the urinary bladder in man
21. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years
22. Bladder cancer following administration of cyclophosphamide
23. Urinary bladder tumors following cyclophosphamide therapy: A report of two cases with a review of the literature
24. Leiomyosarcoma of the urinary bladder: Thirteen years after cyclophosphamide therapy for Hodgkin's disease
25. The incidence of bladder cancer after cyclophosphamide therapy
26. Carcinoma of the bladder complicating cyclophosphamide therapy
27. Does cyclophosphamide induce bladder cancer?
28. Uroepithelial carcinoma in association with cyclophosphamide ingestion
29. Transitional cell carcinoma of the ureter associated with cyclophosphamide therapy for benign disease: A case report
30. Cyclophosphamide hemorrhagic cystitis requiring urinary diversion
31. Hemorrhagic cystitis due to cyclophosphamide
32. Prevention of cyclophosphamide‐induced hemorrhagic cystitis
33. Water intoxication in man after cyclophosphamide therapy: Time course and relation to drug activation
34. Amelioration of cyclophosphamide‐induced cystitis
35. 2 (Letter)
36. Successful management of radiation cystitis with sodium pentosanpolysulfate
37. Prevention of iso‐phosphamide‐induced urothelial toxicity with 2‐mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma
38. The use of sodium 2‐mercaptoethane sulfonate to prevent cyclophosphamide cystitis
39. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: A prospective randomised study
40. Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: Results of a clinical phase II‐study with 151 patients